- Q2 2024 Senzime AB (publ) Earnings Call Transcript1 day ago€0.652 (-10.68%)Earnings
- Q1 2024 Senzime AB (publ) Earnings Call TranscriptMay 07, 2024€0.585 (-2.34%)Earnings
- Q3 2023 Senzime AB (publ) Earnings Call TranscriptOct 26, 2023€0.512 (-3.76%)Earnings
- Q2 2023 Senzime AB (publ) Earnings Call TranscriptAug 24, 2023€0.3985 (+4.18%)Earnings
Q3 2023 Senzime AB (publ) Earnings Call Transcript
Good morning, everyone. Welcome to Erik Penser Bank, this morning's slide presentation of the nine months interim report of Senzime. And here to present the nine month report is CEO, Philip Siberg, very welcome.
()-
Good morning.
Go ahead with your presentation, please.
()-
All right. Thank you, thank you very much. I'm here to kind of give the highlights of the Q3 report that we just published this morning here in Sweden.
So Senzime, just a brief recap. We are a Swedish headquartered medical device company. We're in the midst of a technology and clinical shift where we are providing monitoring solutions to help eliminate complications as a result of anesthesia and also as a result of opioids and other medications as you're in the perioperative mode of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)